Last reviewed · How we verify
NCT03930459: ORGANOXLAFE
Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.
NA trial testing Static cold storage (SCS) in Liver Transplant in 7 participants. Terminated before completion.
4 April 2023
Quick facts
| Lead sponsor | Instituto de Investigacion Sanitaria La Fe |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 7 |
| Start date | 26 April 2019 |
| Primary completion | 4 April 2023 |
| Estimated completion | 4 April 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Static cold storage (SCS)
- Normothermic machine perfusion (NMP)
Conditions studied
- Liver Transplant — all drugs for Liver Transplant →
Sponsor
Instituto de Investigacion Sanitaria La Fe — full company profile →
Who can join
18 and older, any sex, with Liver Transplant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, randomized, controlled clinical trial to determine the overall efficacy of normothermic machine perfusion (NMP) for steatotic liver preservation versus traditional static cold storage (SCS), in 50 liver transplant recipients with 1-year follow-up.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Machine perfusion in liver transplantation.
Tingle SJ, Dobbins JJ, Thompson ER, Figueiredo RS, et al · · 2023 · cited 33× · PMID 37698189 · DOI 10.1002/14651858.cd014685.pub2 -
Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
Matar AJ, Crepeau RL, Mundinger GS, Cetrulo CL, et al · · 2021 · cited 15× · PMID 34276656 · DOI 10.3389/fimmu.2021.664577
Verify or expand the search:
- PubMed search for NCT03930459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Transplant
Currently open trials in the same condition.
- NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
- NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
- NCT07216508 — Liver Transplant CGM · recruiting
- NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
- NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting
Other Instituto de Investigacion Sanitaria La Fe trials
Trials by the same sponsor.
- NCT07402083 — Administration of Extracellular Vesicles From Donor Human Milk in Preterm Infants · recruiting
- NCT07238608 — Impact of UFPs and MNPs on Fetal Health · recruiting
- NCT06950996 — A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and · completed
- NCT06866769 — Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR · recruiting
- NCT07478445 — Home Rehabilitation After Hip Fracture · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03930459 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigacion Sanitaria La Fe
- Last refreshed: 29 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03930459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing